Ripple (XRP) and Shiba Inu (SHIB) Are Yesterday’s News, But These 3 Coins Will Yield a $27000 Profit From $300 Portfolio

Toncoin (TON) prices increased by 20% to $3.48 while its market capitalization exceeded $8.5 billion after Telegrams founder Pavel Durov released the platform. The recent event has led many to believe that Telegram will increase TON adoption rates.

Why Toncoin is Gaining Traction:

• The system enables lightning-fast transactions along with minimal fees which makes it suitable for payment purposes.

• The cryptocurrency transaction process becomes effortless since TON integrates seamlessly with Telegram.

• The DeFi sector continues to expand through rapid growth of staking services and governance functions, as well as lending facilities.

The expansion of blockchain services by Telegram creates conditions for Toncoin to experience increased adoption throughout 2025.

3. Cosmos (ATOM) – The “Internet of Blockchains” is Gaining Momentum

Cosmos (ATOM) reached $4.57 after experiencing its yearly minimum point while attracting over $90 million in open interest from investors. The blockchain interoperability sector continues to recognize Cosmos as one of its top projects.

Why Cosmos Stands Out:

• Seamless blockchain interoperability via the IBC Protocol.

• The Cosmos SDK offers developers tools to create blockchains more efficiently.

• Expanding the DeFi ecosystem, with Osmosis and THORChain driving liquidity.

Cosmos demonstrates its commitment to security by offering $150K to anyone who discovers system weaknesses. ATOM maintains its position as a long-term investment because of ongoing development efforts and DeFi sector expansion.

Why RXS is the Best Bet for 2025

The highest potential for returns belongs to Rexas Finance (RXS) among Toncoin and Cosmos. The combination of real-world assets with deflationary tokenomics and whale accumulation activities creates optimal conditions for a substantial market breakthrough. The upcoming June 19, 2025 exchange launch date of RXS presents investors with a chance to accumulate at its current price of $0.20. Is it time for you to buy RXS before its market value rises？